BIOMAT Database Logo BIOMAT Database Logo

[Various pharmacological and clinical aspects of 1st-, 2d- and 3d-generation cephalosporins (I)]. 1985

A M Barucchi, and A Mazza, and A Pesce, and M Viti

UI MeSH Term Description Entries
D009059 Mouth Diseases Diseases involving the MOUTH. Disease, Mouth,Diseases, Mouth,Mouth Disease
D002435 Cefamandole Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate. Cephamandole,Compound 83405
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D002509 Cephaloridine A cephalosporin antibiotic. Cefaloridine,Cephalomycine,Cephaloridin,Ceporin
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002512 Cephalothin A cephalosporin antibiotic. Cefalotin,Sodium Cephalothin,Cefalotina Normon,Cefalotina Sodica Spaly,Ceftina,Cephalothin Monosodium Salt,Keflin,Seffin,Cephalothin, Sodium,Monosodium Salt, Cephalothin,Salt, Cephalothin Monosodium
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015296 Ceftizoxime A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders. Ceftizoxime Sodium,Cefizox,Ceftizoxime Monosodium Salt,FK-749,FK749,FR-13749,SK&F 88373-2,SKF-88373,FK 749,FR 13749,FR13749,Monosodium Salt, Ceftizoxime,SK&F 88373 2,SK&F 883732,SKF 88373,SKF88373,Salt, Ceftizoxime Monosodium,Sodium, Ceftizoxime

Related Publications

A M Barucchi, and A Mazza, and A Pesce, and M Viti
[In vitro comparison of the antibacterial activity of 1st, 2d, and 3d generation cephalosporins].
September 1983, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
A M Barucchi, and A Mazza, and A Pesce, and M Viti
[Transmission of resistance to 1st and 2d generation cephalosporins].
December 1989, Ceskoslovenska epidemiologie, mikrobiologie, imunologie,
A M Barucchi, and A Mazza, and A Pesce, and M Viti
[Sensitivity of Staphylococcus aureus strains to 2d and 3d generation cephalosporins].
December 1988, Polski tygodnik lekarski (Warsaw, Poland : 1960),
A M Barucchi, and A Mazza, and A Pesce, and M Viti
[Perspectives on the use of 2d and 3d generation cephalosporins in pediatrics].
November 1984, Pediatriia,
A M Barucchi, and A Mazza, and A Pesce, and M Viti
[New 2d generation oral cephalosporins].
March 1987, Ceskoslovenska pediatrie,
A M Barucchi, and A Mazza, and A Pesce, and M Viti
[1st Spanish epidemic of plasmid resistance to 3d generation cephalosporins: the implication of SHV-2].
October 1992, Enfermedades infecciosas y microbiologia clinica,
A M Barucchi, and A Mazza, and A Pesce, and M Viti
[Influence of serum on the minimal inhibitory concentration, the minimal bacterial concentration and bactericidal rate of various 2d and 3d generation cephalosporins].
January 1985, Giornale italiano di chemioterapia,
A M Barucchi, and A Mazza, and A Pesce, and M Viti
[3d generation cephalosporins in nosocomial infections].
March 1983, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
A M Barucchi, and A Mazza, and A Pesce, and M Viti
[Plasmid resistance to 3d generation cephalosporins].
October 1988, Presse medicale (Paris, France : 1983),
A M Barucchi, and A Mazza, and A Pesce, and M Viti
[On the clinical aspects of cephalosporins. I. Bacteriological section].
April 1969, Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology,
Copied contents to your clipboard!